Raffi Tachdjian

Allergy. Immunology. Rare Diseases (ACARE Center) - Raffi Tachdjian MD, Inc.

About Raffi Tachdjian

 

Email UCLAdoc@gmail.com
Main Office Allergy, Immunology, Rare Diseases (ACARE Center), Raffi Tachdjian MD, Inc., 1301 20th Street, Suite 380, Santa Monica, CA 90404
Main Office Phone 310-998-0060
Main Office Fax 310-998-0063
Main Office Website www.DocRaffi.com
Second Office UCLA Ronald Reagan Hospital and Clinics, Allergy, Immunology and Rheumatology Division, 200 Medical Plaza Driveway, Suite 265, Los Angeles, CA 90095
Second Office Phone 310-998-0060
Second Office Website https://www.uclahealth.org/providers/raffi-tachdjian
Education
2004-2007 David Geffen School of Medicine at UCLA; Mattel Children’s Hospital, UCLA Medical Center, Los Angeles, CA; Fellowship in Allergy, Immunology, and Rheumatology
2001-2004 Harvard Medical School; Massachusetts General Hospital, Boston, MA; Internship and Residency in Pediatrics
1997-2001 Morehouse School of Medicine; Grady Memorial Hospital, Atlanta, GA; M.D. Program
1994-1995 Centers for Disease Control & Prevention; National Immunization Program, Atlanta, GA; Association of Schools of Public Health Intern
1993-1994 University of Alabama at Birmingham; School of Public Health, Birmingham, AL; Masters of Public Health (MPH) in Epidemiology
1987-1992 University of California, Los Angeles; Los Angeles, CA; B.S. in Physiological Science
Academic Appointments
2019-present Associate Clinical Professor in Pediatrics, Division of Allergy, Immunology & Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA
2017-present Chief, Division of Allergy & Immunology, Providence St. John’s Medical Center, Santa Monica, CA
Publications
1 Centers for Disease Control and Prevention. Influenza and Pneumococcal Vaccination Coverage Levels Among Persons >65 Years-United States, 1973-1993. MMWR Morb Mortal Wkly Rep. 1995;44:506-515.
2 Guris D, Strebel PM, Tachdjian R, et al. Effectiveness of Pertussis Vaccination Using the Screening Method, United States, 1992-1994. J Infect Dis. 1997;176(2):456-63.
3 Centers for Disease Control and Prevention. Influenza and Pneumococcal Vaccination Levels Among Adults Aged >65 Years-United States, 1997. MMWR Morb Mortal Wkly Rep. 1998;47:797-802.
4 Guris D, Strebel PM, Bardenheier B, Tachdjian R, et al. Changing Epidemiology of Pertussis in the U.S. Clin Infect Dis. 1999;28(6):1230-7.
5 Brennan M, Strebel P, George H, Yih KW, Tachdjian R, et al. Evidence for Transmission of Pertussis in Schools. J Infect Dis. 2000;181:210-5.
6 Vincent JM, Cherry JD, Nauschuetz WF, Lipton A, Ono CM, Costello CN, Sakaguchi LK, Hsue G, Jackson LA, Tachdjian R, et al. Prolonged Afebrile Nonproductive Cough Illnesses in American Soldiers in Korea. Clin Infect Dis. 2000;30(3):534-539.
7 Tachdjian R, Singleton J, Strikas RA, Williams WW, Baughman AL. Factors Associated with Influenza Vaccination Among Persons with Diabetes.
8 Phipatanakul W, Cronin B, Wood RA, Eggleston PA, Shih MC, Song L, Tachdjian R, Oettgen HC. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol. 2004;92(4):420-5.
9 Chang AD, Tachdjian R, Gallagher K, McCurdy DK, Lassman C, Stiehm ER, Yadin O. Type III Mixed Cryoglobulinemia and Antiphospholipid Syndrome in a Patient with Partial DiGeorge Syndrome. Clin Dev Immunol. 2006;13(2-4):261-264.
10 Tachdjian R, Mathias C, Al Khatib S, Bryce PJ, Kim HS, Blaeser F, O’Connor BD, Rzymkiewicz D, Chen A, Holtzman MJ, Hershey GK, Garn H, Harb H, Renz H, Oettgen HC, Chatila TA. Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J Exp Med. 2009;206(10):2191-204.

Specialty

Disclosures

Receipt of grants/research support: Adma, Kalvista Receipt of honoraria or consultation fee: BioCryst, CSL Behring, Ionis, Pharvaris, Kalvista, Intellia, Takeda